Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death

Clinical Chemistry

Volumn 47, Issue 7, 2001, Pages 1166-1182

  Chace, D H ^a   DiPerna, J C ^a   Mitchell, B L ^a   Sgroi, B ^a   Hofman, L F ^a   Naylor, E W ^a  

^a Neo Gen Screening   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLBUTYRIC ACID; 3 HYDROXYACYL COENZYME A DEHYDROGENASE; ACYLCARNITINE; CARNITINE PALMITOYLTRANSFERASE; GLUTARIC ACID; ISOVALERIC ACID; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; VERY LONG CHAIN FATTY ACID;

AMINO ACID METABOLISM; ARTICLE; AUTOPSY; BLOOD ANALYSIS; CAUSE OF DEATH; CHILD DEATH; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENZYME DEFICIENCY; FATTY ACID OXIDATION; HUMAN; INBORN ERROR OF METABOLISM; INFANT; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY;

EID: 0034956576     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.7.1166     Document Type: Article

References (37)

1. Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver
2. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life
3. Sudden and unexpected neonatal death: A protocol for the postmortem diagnosis of fatty acid oxidation disorders
4. Fatty acid oxidation defects as causes of unexpected death in infancy
5. Metabolic disease and sudden, unexpected death in infancy
6. Inherited metabolic diseases in the sudden infant death syndrome
7. Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: An investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years
8. Evidence of duration and type of illness in children found unexpectedly dead
9. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: Neonatal screening shows high incidence and unexpected mutation frequencies
10. Medium-chain acyl-CoA dehydrogenase deficiency: Postmortem diagnosis in a case of sudden infant death and neonatal diagnosis of an affected sibling
11. Medium-chain acyl-coenzyme A dehydrogenase deficiency and sudden infant death
12. Carnitine and acylcarnitines in metabolic disease diagnosis and management
13. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders
14. Medium-chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children
15. Prenatal diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in a family with a previous fatal case of sudden unexpected death in childhood
16. Diagnosis of mitochondrial trifunctional protein deficiency in a blood spot from the newborn screening card by tandem mass spectrometry and DNA analysis
17. Sudden infant death syndrome and multiple acyl-coenzyme A dehydrogenase deficiency, ethylmalonic-adipic aciduria, or systemic carnitine deficiency
18. Sudden infant death syndrome and inherited disorders of fatty acid beta-oxidation
19. Sudden neonatal death in carnitine transporter deficiency
20. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Diagnosis by acylcarnitine analysis in blood
21. Comment on "Whole blood levels of dodecanoic acid, a routinely detectable forensic marker for a genetic disease often misdiagnosed as sudden infant death syndrome (SIDS): MCAD deficiency"
22. Rapid diagnosis of MCAD deficiency: Quantitatively analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry
23. Mass spectrometry in the clinical laboratory
24. Whole blood levels of dodecanoic acid, a routinely detectable forensic marker for a genetic disease often misdiagnosed as sudden infant death syndrome (SIDS): MCAD deficiency
25. Comparison of postmortem urinary and vitreous humour organic acids
26. The analysis of diagnostic markers of genetic disorders in human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry
27. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile
28. Expansion of newborn screening programs using automated tandem mass spectrometry
29. Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: A model for clinical mass spectrometry in the next millennium
30. Infant mortality statistics from the 1997 period linked birth/infant death data set
31. Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry
32. Recoveries of phenylalanine from two sets of dried-blood-spot reference materials: Prediction from hematocrit, spot volume, and paper matrix
33. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry
34. Validation of accuracy-based amino acid reference materials in dried-blood spots by tandem mass spectrometry for newborn screening assays
35. Disorders of fatty acid transport and mitochondrial oxidation: Challenges and dilemmas of metabolic evaluation
36. Clinical and biochemical features of fatty acid oxidation disorders